Work

94P First-line chemotherapy plus immunotherapy versus chemotherapy alone for advanced gallbladder carcinoma

Year: 2023

Type: article

Abstract: Gallbladder carcinoma (GBC) is a highly malignant tumor of the biliary tract. The prognosis for advanced GBC is generally very poor with scarce evidence on effective treatment options. In light of the limited therapeutic strategies, this study aims to shed light on the outcomes of using chemotherapy alone or in combination with PD-1 inhibitor as the first-line therapy.

Source: Immuno-Oncology Technology

DOI: 10.1016/j.iotech.2023.100566

Authors: Q-Q. Liu, J. Yan, C-N. Yang, Z-J. Chen, H-M. Lin, R. Zhang

Institutions: Sun Yat-sen University, Sun Yat-sen Memorial Hospital

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,020